<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 2054
Form 12b-25
NOTIFICATION OF LATE FILING
Form 10-K Form 20-F Form 11-K X Form 10-Q Form N-SAR
----- ----- ----- ----- -----
Commission file number 0-23812
--------
BioPulse International, Inc.
-----------------------------
Full Name of Registrant
N/A
--------
Former Name of Registrant
10421 South Jordan Gateway, Suite 500
---------------------------------------
Address of Principal Executive Offices (Street and Number)
South Jordan, Utah 84095
--------------------------
City, State and Zip Code
PART II - RULES 12b-25 (b) AND (c)
If the subject could be filed without unreasonable effort or expense and
the Registrant seeks relief pursuant to Rule 12b-25 (b), the following
should be completed. (Check if appropriate).
X (a) The reasons described in reasonable detail in Part III of
---------- this form could not eliminated without unreasonable effort
of expense;
X (b) The subject annual report, semi-annual report, transition
---------- report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR, or
portion thereof, will be filed on or before the fifteenth
calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q,
or portion thereof will be filed on or before the fifth
calendar day following the prescribed due date; and
(c) The accountant's statements or other exhibit required by
---------- Rule 12b-25 (c) has been attached if applicable.
PART III - NARRATIVE
The Company was delayed in compiling certain financial information
necessary for it to complete its financial statements for the quarter ended
April 30, 2000. This delay could not be avoided without unreasonable
effort or expense. The Company expects to complete the financial
statements and file its quarterly report on Form 10-QSB on or before June
19, 2000.
</Page>
<PAGE>
PART IV - OTHER INFORMATION
1. Name and telephone number of person to contact in regard to this
notification.
Jonathan Neville 801 523-0101
----------------- ---------- ------------------
(Name) (Area Code) (Telephone Number)
2. Have all other periodic reports required under Section 13 or 15 (b) of
the Securities and Exchange Act of 1934 or Section 30 or the
Investments Act of 1940 during the preceding 12 months (or for such
shorter) period that the Registrant was required to file such reports
been filed? If answer is no, identify report(s).
X Yes No
------ ------
3. There are not any significant changes anticipated in the results of
operations from the corresponding period of the last fiscal quarter
that will be reflected by the earnings statements to be included in
the subject report or portion thereof.
</Page>
<PAGE>
BIOPULSE INTERNATIONAL, INC.
----------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: June 14, 2000 By: /s/ Jonathan Neville
----------------------------
Jonathan Neville
President
</Page>
